Form 8-K - Current report:
SEC Accession No. 0001628280-22-003244
Filing Date
2022-02-22
Accepted
2022-02-22 07:36:15
Documents
13
Period of Report
2022-02-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ocgn-20220218.htm   iXBRL 8-K 35982
2 EX-99.1 ocgn-20220222xex991.htm EX-99.1 12346
  Complete submission text file 0001628280-22-003244.txt   188247

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocgn-20220218.xsd EX-101.SCH 1896
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocgn-20220218_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocgn-20220218_pre.xml EX-101.PRE 12504
7 EXTRACTED XBRL INSTANCE DOCUMENT ocgn-20220218_htm.xml XML 10627
Mailing Address 263 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 263 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 22655001
SIC: 2836 Biological Products, (No Diagnostic Substances)